Abstract
Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition. Teprotumumab is a human insulin-like growth factor-I receptor monoclonal inhibitor antibody which ...
Funding Information
  • funded

This publication has 39 references indexed in Scilit: